Twist Bioscience (TWST) Depreciation & Amortization (CF) (2017 - 2025)

Twist Bioscience (TWST) has disclosed Depreciation & Amortization (CF) for 7 consecutive years, with $8.5 million as the latest value for Q3 2023.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 71.65% to $8.5 million in Q3 2023 year-over-year; TTM through Sep 2023 was $29.3 million, a 77.49% increase, with the full-year FY2025 number at $24.9 million, down 20.93% from a year prior.
  • Depreciation & Amortization (CF) was $8.5 million for Q3 2023 at Twist Bioscience, roughly flat from $8.5 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $8.5 million in Q3 2023 to a low of $1.5 million in Q3 2019.
  • A 5-year average of $3.5 million and a median of $2.5 million in 2021 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): dropped 6.48% in 2019, then surged 99.6% in 2022.
  • Twist Bioscience's Depreciation & Amortization (CF) stood at $1.5 million in 2019, then skyrocketed by 40.27% to $2.1 million in 2020, then skyrocketed by 49.22% to $3.2 million in 2021, then soared by 68.0% to $5.3 million in 2022, then soared by 60.62% to $8.5 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Depreciation & Amortization (CF) are $8.5 million (Q3 2023), $8.5 million (Q2 2023), and $7.0 million (Q1 2023).